nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—Phase II conjugation—GSTA3—lung cancer	0.00509	0.0203	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—GSTA4—lung cancer	0.00466	0.0185	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—GSTA2—lung cancer	0.00454	0.0181	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—GSTA1—lung cancer	0.00438	0.0174	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—UGT1A1—lung cancer	0.00407	0.0162	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTM2—lung cancer	0.0037	0.0147	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—CNDP2—lung cancer	0.0037	0.0147	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—HPGDS—lung cancer	0.00346	0.0138	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—GSTT1—lung cancer	0.00336	0.0134	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—CYP2A7—lung cancer	0.00334	0.0133	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—GCLC—lung cancer	0.00332	0.0132	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTA3—lung cancer	0.00298	0.0119	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTA4—lung cancer	0.00273	0.0108	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTA2—lung cancer	0.00266	0.0106	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTA1—lung cancer	0.00256	0.0102	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—UGT1A1—lung cancer	0.00238	0.00948	CbGpPWpGaD
Lorazepam—UGT2B15—Phase II conjugation—GSTP1—lung cancer	0.00233	0.00926	CbGpPWpGaD
Lorazepam—UGT2B15—mammary gland—lung cancer	0.00219	0.376	CbGeAlD
Lorazepam—UGT2B15—Phase II conjugation—GSTM1—lung cancer	0.00214	0.00851	CbGpPWpGaD
Lorazepam—Diclofenac—UGT1A1—lung cancer	0.00209	0.122	CrCbGaD
Lorazepam—GABRB3—GABA receptor activation—ADCY1—lung cancer	0.00209	0.00831	CbGpPWpGaD
Lorazepam—GABRG2—GABA receptor activation—ADCY1—lung cancer	0.00205	0.00816	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—HPGDS—lung cancer	0.00203	0.00806	CbGpPWpGaD
Lorazepam—Diclofenac—CXCL8—lung cancer	0.00198	0.115	CrCbGaD
Lorazepam—UGT2B15—Biological oxidations—GSTT1—lung cancer	0.00196	0.00782	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GCLC—lung cancer	0.00194	0.00773	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—CYP2A6—lung cancer	0.00194	0.00773	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.00183	0.00727	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.0018	0.00714	CbGpPWpGaD
Lorazepam—GABRA1—GABA receptor activation—ADCY1—lung cancer	0.00179	0.00713	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—CYP2E1—lung cancer	0.00165	0.00657	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.00157	0.00624	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.00149	0.00593	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.00146	0.00582	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.00139	0.00551	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00137	0.00547	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTP1—lung cancer	0.00136	0.00542	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.00136	0.00541	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00135	0.00537	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.00128	0.00509	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—GSTM1—lung cancer	0.00125	0.00498	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.00119	0.00473	CbGpPWpGaD
Lorazepam—UGT2B15—Biological oxidations—CYP1A1—lung cancer	0.00119	0.00472	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00118	0.00469	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00117	0.00467	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.00113	0.00449	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00112	0.00446	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.00111	0.00441	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.0011	0.00438	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.00107	0.00425	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIK3—lung cancer	0.00105	0.00419	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.00105	0.00417	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—COL4A3BP—lung cancer	0.00104	0.00415	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AZIN2—lung cancer	0.00104	0.00415	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00104	0.00414	CbGpPWpGaD
Lorazepam—Bromazepam—CYP2E1—lung cancer	0.00104	0.0605	CrCbGaD
Lorazepam—GABRG2—Neuronal System—GRIK3—lung cancer	0.00103	0.00411	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00102	0.00407	CbGpPWpGaD
Lorazepam—Clonazepam—CYP2E1—lung cancer	0.000975	0.0567	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.000969	0.00386	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000962	0.00383	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.00096	0.00382	CbGpPWpGaD
Lorazepam—Visual disturbance—Methotrexate—lung cancer	0.000951	0.00131	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.000943	0.00375	CbGpPWpGaD
Lorazepam—Hypertension—Irinotecan—lung cancer	0.000941	0.0013	CcSEcCtD
Lorazepam—Jaundice—Docetaxel—lung cancer	0.000939	0.00129	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—NCAM1—lung cancer	0.000939	0.00374	CbGpPWpGaD
Lorazepam—Diclofenac—CYP2E1—lung cancer	0.000934	0.0544	CrCbGaD
Lorazepam—Chills—Etoposide—lung cancer	0.000934	0.00129	CcSEcCtD
Lorazepam—Mental disability—Doxorubicin—lung cancer	0.000933	0.00129	CcSEcCtD
Lorazepam—Vision blurred—Cisplatin—lung cancer	0.000932	0.00128	CcSEcCtD
Lorazepam—Asthenia—Vinblastine—lung cancer	0.000931	0.00128	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000931	0.00128	CcSEcCtD
Lorazepam—Fatigue—Vinorelbine—lung cancer	0.000929	0.00128	CcSEcCtD
Lorazepam—Hypersensitivity—Topotecan—lung cancer	0.000928	0.00128	CcSEcCtD
Lorazepam—Tremor—Cisplatin—lung cancer	0.000927	0.00128	CcSEcCtD
Lorazepam—Pain—Vinorelbine—lung cancer	0.000922	0.00127	CcSEcCtD
Lorazepam—Constipation—Vinorelbine—lung cancer	0.000922	0.00127	CcSEcCtD
Lorazepam—Diclofenac—CYP1A1—lung cancer	0.000922	0.0537	CrCbGaD
Lorazepam—Alopecia—Etoposide—lung cancer	0.00092	0.00127	CcSEcCtD
Lorazepam—Lethargy—Methotrexate—lung cancer	0.00092	0.00127	CcSEcCtD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.000917	0.00365	CbGpPWpGaD
Lorazepam—Hypertension—Gemcitabine—lung cancer	0.000916	0.00126	CcSEcCtD
Lorazepam—Chills—Paclitaxel—lung cancer	0.000916	0.00126	CcSEcCtD
Lorazepam—Arrhythmia—Paclitaxel—lung cancer	0.000912	0.00126	CcSEcCtD
Lorazepam—Asthenia—Topotecan—lung cancer	0.000904	0.00125	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—GRIK3—lung cancer	0.000904	0.0036	CbGpPWpGaD
Lorazepam—Alopecia—Paclitaxel—lung cancer	0.000902	0.00124	CcSEcCtD
Lorazepam—Osteoarthritis—Methotrexate—lung cancer	0.000901	0.00124	CcSEcCtD
Lorazepam—Agranulocytosis—Docetaxel—lung cancer	0.000899	0.00124	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.000897	0.00124	CcSEcCtD
Lorazepam—Confusional state—Irinotecan—lung cancer	0.000896	0.00124	CcSEcCtD
Lorazepam—Asthenia—Erlotinib—lung cancer	0.000895	0.00123	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000894	0.00356	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000889	0.00354	CbGpPWpGaD
Lorazepam—Erythema—Paclitaxel—lung cancer	0.000888	0.00122	CcSEcCtD
Lorazepam—Feeling abnormal—Vinorelbine—lung cancer	0.000888	0.00122	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ATP5H—lung cancer	0.000887	0.00353	CbGpPWpGaD
Lorazepam—Flurazepam—CYP2A6—lung cancer	0.000884	0.0515	CrCbGaD
Lorazepam—UGT2B15—Biological oxidations—POMC—lung cancer	0.000884	0.00352	CbGpPWpGaD
Lorazepam—Infection—Irinotecan—lung cancer	0.000883	0.00122	CcSEcCtD
Lorazepam—Tension—Paclitaxel—lung cancer	0.000872	0.0012	CcSEcCtD
Lorazepam—Thrombocytopenia—Irinotecan—lung cancer	0.00087	0.0012	CcSEcCtD
Lorazepam—Nervousness—Paclitaxel—lung cancer	0.000863	0.00119	CcSEcCtD
Lorazepam—Infection—Gemcitabine—lung cancer	0.00086	0.00119	CcSEcCtD
Lorazepam—Irritability—Methotrexate—lung cancer	0.00086	0.00119	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—CHRNB4—lung cancer	0.000858	0.00342	CbGpPWpGaD
Lorazepam—Dizziness—Vinblastine—lung cancer	0.000858	0.00118	CcSEcCtD
Lorazepam—Convulsion—Cisplatin—lung cancer	0.000857	0.00118	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000849	0.00338	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Gemcitabine—lung cancer	0.000848	0.00117	CcSEcCtD
Lorazepam—Ataxia—Methotrexate—lung cancer	0.000847	0.00117	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—CHRNB4—lung cancer	0.000843	0.00335	CbGpPWpGaD
Lorazepam—Vision blurred—Paclitaxel—lung cancer	0.000837	0.00115	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000834	0.00332	CbGpPWpGaD
Lorazepam—Visual impairment—Docetaxel—lung cancer	0.000834	0.00115	CcSEcCtD
Lorazepam—Dizziness—Topotecan—lung cancer	0.000833	0.00115	CcSEcCtD
Lorazepam—Tremor—Paclitaxel—lung cancer	0.000832	0.00115	CcSEcCtD
Lorazepam—Liver function test abnormal—Methotrexate—lung cancer	0.000832	0.00115	CcSEcCtD
Lorazepam—Hypotension—Irinotecan—lung cancer	0.000831	0.00114	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000827	0.00329	CbGpPWpGaD
Lorazepam—Vomiting—Vinblastine—lung cancer	0.000825	0.00114	CcSEcCtD
Lorazepam—Dizziness—Erlotinib—lung cancer	0.000824	0.00114	CcSEcCtD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.000824	0.00328	CbGpPWpGaD
Lorazepam—Agitation—Paclitaxel—lung cancer	0.000816	0.00113	CcSEcCtD
Lorazepam—Vertigo—Etoposide—lung cancer	0.000814	0.00112	CcSEcCtD
Lorazepam—Headache—Vinblastine—lung cancer	0.000813	0.00112	CcSEcCtD
Lorazepam—Hypotension—Gemcitabine—lung cancer	0.000809	0.00112	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000804	0.0032	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GNG11—lung cancer	0.000803	0.00319	CbGpPWpGaD
Lorazepam—Infection—Cisplatin—lung cancer	0.000802	0.00111	CcSEcCtD
Lorazepam—Vomiting—Topotecan—lung cancer	0.000801	0.0011	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.0008	0.00319	CbGpPWpGaD
Lorazepam—Vertigo—Paclitaxel—lung cancer	0.000798	0.0011	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—CHRNA5—lung cancer	0.000798	0.00318	CbGpPWpGaD
Lorazepam—Lethargy—Doxorubicin—lung cancer	0.000796	0.0011	CcSEcCtD
Lorazepam—Rash—Topotecan—lung cancer	0.000795	0.00109	CcSEcCtD
Lorazepam—Hypersensitivity—Vinorelbine—lung cancer	0.000794	0.00109	CcSEcCtD
Lorazepam—Dermatitis—Topotecan—lung cancer	0.000794	0.00109	CcSEcCtD
Lorazepam—Vomiting—Erlotinib—lung cancer	0.000793	0.00109	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—PLBD1—lung cancer	0.000791	0.00315	CbGpPWpGaD
Lorazepam—Somnolence—Irinotecan—lung cancer	0.00079	0.00109	CcSEcCtD
Lorazepam—Thrombocytopenia—Cisplatin—lung cancer	0.00079	0.00109	CcSEcCtD
Lorazepam—Headache—Topotecan—lung cancer	0.000789	0.00109	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000789	0.00314	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GNG11—lung cancer	0.000788	0.00314	CbGpPWpGaD
Lorazepam—Tachycardia—Cisplatin—lung cancer	0.000788	0.00109	CcSEcCtD
Lorazepam—Rash—Erlotinib—lung cancer	0.000786	0.00108	CcSEcCtD
Lorazepam—Dermatitis—Erlotinib—lung cancer	0.000785	0.00108	CcSEcCtD
Lorazepam—Convulsion—Etoposide—lung cancer	0.000785	0.00108	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—CHRNA5—lung cancer	0.000784	0.00312	CbGpPWpGaD
Lorazepam—Hyponatraemia—Doxorubicin—lung cancer	0.000784	0.00108	CcSEcCtD
Lorazepam—Hypertension—Etoposide—lung cancer	0.000782	0.00108	CcSEcCtD
Lorazepam—Headache—Erlotinib—lung cancer	0.000781	0.00108	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.00078	0.00108	CcSEcCtD
Lorazepam—Diplopia—Doxorubicin—lung cancer	0.00078	0.00108	CcSEcCtD
Lorazepam—Osteoarthritis—Doxorubicin—lung cancer	0.00078	0.00108	CcSEcCtD
Lorazepam—Chills—Docetaxel—lung cancer	0.000776	0.00107	CcSEcCtD
Lorazepam—Asthenia—Vinorelbine—lung cancer	0.000773	0.00107	CcSEcCtD
Lorazepam—Arrhythmia—Docetaxel—lung cancer	0.000773	0.00106	CcSEcCtD
Lorazepam—Nausea—Vinblastine—lung cancer	0.000771	0.00106	CcSEcCtD
Lorazepam—Somnolence—Gemcitabine—lung cancer	0.00077	0.00106	CcSEcCtD
Lorazepam—Convulsion—Paclitaxel—lung cancer	0.00077	0.00106	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Irinotecan—lung cancer	0.000768	0.00106	CcSEcCtD
Lorazepam—Hypertension—Paclitaxel—lung cancer	0.000767	0.00106	CcSEcCtD
Lorazepam—Fatigue—Irinotecan—lung cancer	0.000767	0.00106	CcSEcCtD
Lorazepam—Alopecia—Docetaxel—lung cancer	0.000764	0.00105	CcSEcCtD
Lorazepam—Pain—Irinotecan—lung cancer	0.00076	0.00105	CcSEcCtD
Lorazepam—Constipation—Irinotecan—lung cancer	0.00076	0.00105	CcSEcCtD
Lorazepam—Hypotension—Cisplatin—lung cancer	0.000754	0.00104	CcSEcCtD
Lorazepam—Erythema—Docetaxel—lung cancer	0.000753	0.00104	CcSEcCtD
Lorazepam—Nausea—Topotecan—lung cancer	0.000749	0.00103	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000748	0.00103	CcSEcCtD
Lorazepam—Fatigue—Gemcitabine—lung cancer	0.000747	0.00103	CcSEcCtD
Lorazepam—Confusional state—Etoposide—lung cancer	0.000746	0.00103	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—lung cancer	0.000742	0.00102	CcSEcCtD
Lorazepam—Constipation—Gemcitabine—lung cancer	0.000741	0.00102	CcSEcCtD
Lorazepam—Pain—Gemcitabine—lung cancer	0.000741	0.00102	CcSEcCtD
Lorazepam—Nausea—Erlotinib—lung cancer	0.000741	0.00102	CcSEcCtD
Lorazepam—Pancytopenia—Methotrexate—lung cancer	0.00074	0.00102	CcSEcCtD
Lorazepam—Dry mouth—Paclitaxel—lung cancer	0.00074	0.00102	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—CHRNB4—lung cancer	0.000737	0.00293	CbGpPWpGaD
Lorazepam—Infection—Etoposide—lung cancer	0.000735	0.00101	CcSEcCtD
Lorazepam—Ataxia—Doxorubicin—lung cancer	0.000734	0.00101	CcSEcCtD
Lorazepam—Feeling abnormal—Irinotecan—lung cancer	0.000733	0.00101	CcSEcCtD
Lorazepam—Confusional state—Paclitaxel—lung cancer	0.000731	0.00101	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000729	0.0029	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Etoposide—lung cancer	0.000724	0.000998	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—HSD17B10—lung cancer	0.000723	0.00288	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000722	0.00287	CbGpPWpGaD
Lorazepam—Tachycardia—Etoposide—lung cancer	0.000722	0.000995	CcSEcCtD
Lorazepam—Liver function test abnormal—Doxorubicin—lung cancer	0.00072	0.000993	CcSEcCtD
Lorazepam—Infection—Paclitaxel—lung cancer	0.00072	0.000993	CcSEcCtD
Lorazepam—Erectile dysfunction—Methotrexate—lung cancer	0.000717	0.000989	CcSEcCtD
Lorazepam—Feeling abnormal—Gemcitabine—lung cancer	0.000714	0.000983	CcSEcCtD
Lorazepam—Dizziness—Vinorelbine—lung cancer	0.000713	0.000982	CcSEcCtD
Lorazepam—Thrombocytopenia—Paclitaxel—lung cancer	0.00071	0.000978	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000709	0.00282	CbGpPWpGaD
Lorazepam—Tachycardia—Paclitaxel—lung cancer	0.000708	0.000975	CcSEcCtD
Lorazepam—Nitrazepam—CYP2E1—lung cancer	0.000706	0.0411	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TF—lung cancer	0.000703	0.0028	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Cisplatin—lung cancer	0.000697	0.00096	CcSEcCtD
Lorazepam—Drowsiness—Methotrexate—lung cancer	0.000695	0.000957	CcSEcCtD
Lorazepam—Clozapine—CYP2A6—lung cancer	0.000694	0.0404	CrCbGaD
Lorazepam—Hypotension—Etoposide—lung cancer	0.000691	0.000952	CcSEcCtD
Lorazepam—Pain—Cisplatin—lung cancer	0.00069	0.000951	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00069	0.00274	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GNG11—lung cancer	0.000689	0.00274	CbGpPWpGaD
Lorazepam—Vomiting—Vinorelbine—lung cancer	0.000685	0.000945	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—CHRNA5—lung cancer	0.000685	0.00273	CbGpPWpGaD
Lorazepam—Rash—Vinorelbine—lung cancer	0.00068	0.000937	CcSEcCtD
Lorazepam—Dermatitis—Vinorelbine—lung cancer	0.000679	0.000936	CcSEcCtD
Lorazepam—Hypotension—Paclitaxel—lung cancer	0.000678	0.000934	CcSEcCtD
Lorazepam—Headache—Vinorelbine—lung cancer	0.000675	0.000931	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CKB—lung cancer	0.000672	0.00268	CbGpPWpGaD
Lorazepam—Feeling abnormal—Cisplatin—lung cancer	0.000665	0.000917	CcSEcCtD
Lorazepam—Somnolence—Etoposide—lung cancer	0.000657	0.000906	CcSEcCtD
Lorazepam—Hypersensitivity—Irinotecan—lung cancer	0.000655	0.000903	CcSEcCtD
Lorazepam—Convulsion—Docetaxel—lung cancer	0.000652	0.000899	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—CHRNA3—lung cancer	0.000651	0.00259	CbGpPWpGaD
Lorazepam—Hypertension—Docetaxel—lung cancer	0.00065	0.000896	CcSEcCtD
Lorazepam—Agranulocytosis—Methotrexate—lung cancer	0.000648	0.000893	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—FOXO3—lung cancer	0.000646	0.00257	CbGpPWpGaD
Lorazepam—Somnolence—Paclitaxel—lung cancer	0.000645	0.000888	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—lung cancer	0.000641	0.000883	CcSEcCtD
Lorazepam—Nausea—Vinorelbine—lung cancer	0.00064	0.000882	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—CHRNA3—lung cancer	0.000639	0.00254	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Etoposide—lung cancer	0.000638	0.00088	CcSEcCtD
Lorazepam—Asthenia—Irinotecan—lung cancer	0.000638	0.000879	CcSEcCtD
Lorazepam—Fatigue—Etoposide—lung cancer	0.000638	0.000879	CcSEcCtD
Lorazepam—Constipation—Etoposide—lung cancer	0.000632	0.000871	CcSEcCtD
Lorazepam—Pain—Etoposide—lung cancer	0.000632	0.000871	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CNDP2—lung cancer	0.000632	0.00252	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTM2—lung cancer	0.000632	0.00252	CbGpPWpGaD
Lorazepam—Flurazepam—CYP2E1—lung cancer	0.000628	0.0366	CrCbGaD
Lorazepam—Dry mouth—Docetaxel—lung cancer	0.000627	0.000864	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000626	0.000863	CcSEcCtD
Lorazepam—Fatigue—Paclitaxel—lung cancer	0.000625	0.000861	CcSEcCtD
Lorazepam—Asthenia—Gemcitabine—lung cancer	0.000621	0.000856	CcSEcCtD
Lorazepam—Pain—Paclitaxel—lung cancer	0.00062	0.000854	CcSEcCtD
Lorazepam—Constipation—Paclitaxel—lung cancer	0.00062	0.000854	CcSEcCtD
Lorazepam—Confusional state—Docetaxel—lung cancer	0.00062	0.000854	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.00062	0.00247	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GNG11—lung cancer	0.000615	0.00245	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTMR3—lung cancer	0.000615	0.00245	CbGpPWpGaD
Lorazepam—Infection—Docetaxel—lung cancer	0.000611	0.000841	CcSEcCtD
Lorazepam—Feeling abnormal—Etoposide—lung cancer	0.000609	0.00084	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000609	0.00242	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GNG11—lung cancer	0.000604	0.0024	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Docetaxel—lung cancer	0.000602	0.000829	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—lung cancer	0.000601	0.000829	CcSEcCtD
Lorazepam—Visual impairment—Methotrexate—lung cancer	0.000601	0.000828	CcSEcCtD
Lorazepam—Tachycardia—Docetaxel—lung cancer	0.0006	0.000827	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—PGAM1—lung cancer	0.000599	0.00238	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000598	0.00238	CbGpPWpGaD
Lorazepam—Feeling abnormal—Paclitaxel—lung cancer	0.000598	0.000823	CcSEcCtD
Lorazepam—Hypersensitivity—Cisplatin—lung cancer	0.000595	0.00082	CcSEcCtD
Lorazepam—Dizziness—Irinotecan—lung cancer	0.000588	0.00081	CcSEcCtD
Lorazepam—Jaundice—Doxorubicin—lung cancer	0.000586	0.000808	CcSEcCtD
Lorazepam—Midazolam—CYP2E1—lung cancer	0.000582	0.0339	CrCbGaD
Lorazepam—Asthenia—Cisplatin—lung cancer	0.000579	0.000798	CcSEcCtD
Lorazepam—Diclofenac—PTGS2—lung cancer	0.000576	0.0335	CrCbGaD
Lorazepam—Hypotension—Docetaxel—lung cancer	0.000574	0.000791	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CYP2A7—lung cancer	0.000572	0.00227	CbGpPWpGaD
Lorazepam—Vomiting—Irinotecan—lung cancer	0.000565	0.000779	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—lung cancer	0.000561	0.000773	CcSEcCtD
Lorazepam—Rash—Irinotecan—lung cancer	0.000561	0.000772	CcSEcCtD
Lorazepam—Dermatitis—Irinotecan—lung cancer	0.00056	0.000772	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—SDC4—lung cancer	0.000559	0.00223	CbGpPWpGaD
Lorazepam—Chills—Methotrexate—lung cancer	0.000559	0.000771	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—CHRNA3—lung cancer	0.000558	0.00222	CbGpPWpGaD
Lorazepam—Headache—Irinotecan—lung cancer	0.000557	0.000768	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—ADCY1—lung cancer	0.000553	0.0022	CbGpPWpGaD
Lorazepam—Alopecia—Methotrexate—lung cancer	0.000551	0.000759	CcSEcCtD
Lorazepam—Vomiting—Gemcitabine—lung cancer	0.000551	0.000759	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—lung cancer	0.00055	0.000757	CcSEcCtD
Lorazepam—Somnolence—Docetaxel—lung cancer	0.000546	0.000753	CcSEcCtD
Lorazepam—Rash—Gemcitabine—lung cancer	0.000546	0.000752	CcSEcCtD
Lorazepam—Dermatitis—Gemcitabine—lung cancer	0.000546	0.000752	CcSEcCtD
Lorazepam—Hypersensitivity—Etoposide—lung cancer	0.000545	0.000751	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—ADCY1—lung cancer	0.000543	0.00216	CbGpPWpGaD
Lorazepam—Erythema—Methotrexate—lung cancer	0.000543	0.000748	CcSEcCtD
Lorazepam—Headache—Gemcitabine—lung cancer	0.000543	0.000748	CcSEcCtD
Lorazepam—Clonazepam—ALB—lung cancer	0.000535	0.0312	CrCbGaD
Lorazepam—Hypersensitivity—Paclitaxel—lung cancer	0.000534	0.000736	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Docetaxel—lung cancer	0.000531	0.000731	CcSEcCtD
Lorazepam—Asthenia—Etoposide—lung cancer	0.000531	0.000731	CcSEcCtD
Lorazepam—Fatigue—Docetaxel—lung cancer	0.00053	0.00073	CcSEcCtD
Lorazepam—Nausea—Irinotecan—lung cancer	0.000528	0.000728	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—GNG11—lung cancer	0.000528	0.0021	CbGpPWpGaD
Lorazepam—Pain—Docetaxel—lung cancer	0.000526	0.000724	CcSEcCtD
Lorazepam—Constipation—Docetaxel—lung cancer	0.000526	0.000724	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000523	0.00208	CbGpPWpGaD
Lorazepam—TSPO—respiratory system—lung cancer	0.000522	0.0896	CbGeAlD
Lorazepam—Visual impairment—Doxorubicin—lung cancer	0.00052	0.000717	CcSEcCtD
Lorazepam—Asthenia—Paclitaxel—lung cancer	0.00052	0.000717	CcSEcCtD
Lorazepam—Nausea—Gemcitabine—lung cancer	0.000514	0.000709	CcSEcCtD
Lorazepam—Diclofenac—ALB—lung cancer	0.000513	0.0299	CrCbGaD
Lorazepam—Vomiting—Cisplatin—lung cancer	0.000513	0.000707	CcSEcCtD
Lorazepam—Vision blurred—Methotrexate—lung cancer	0.000512	0.000705	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—RRM1—lung cancer	0.00051	0.00203	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTA3—lung cancer	0.00051	0.00203	CbGpPWpGaD
Lorazepam—Rash—Cisplatin—lung cancer	0.000509	0.000701	CcSEcCtD
Lorazepam—Dermatitis—Cisplatin—lung cancer	0.000508	0.000701	CcSEcCtD
Lorazepam—GABRB3—Orphan transporters—CREBBP—lung cancer	0.000508	0.00202	CbGpPWpGaD
Lorazepam—Feeling abnormal—Docetaxel—lung cancer	0.000506	0.000698	CcSEcCtD
Lorazepam—GABRG2—Orphan transporters—CREBBP—lung cancer	0.000499	0.00199	CbGpPWpGaD
Lorazepam—Diazepam—CYP2E1—lung cancer	0.000499	0.029	CrCbGaD
Lorazepam—Clozapine—CYP2E1—lung cancer	0.000493	0.0287	CrCbGaD
Lorazepam—Diclofenac—ABCB1—lung cancer	0.00049	0.0285	CrCbGaD
Lorazepam—Dizziness—Etoposide—lung cancer	0.000489	0.000674	CcSEcCtD
Lorazepam—Vertigo—Methotrexate—lung cancer	0.000488	0.000672	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000487	0.00194	CbGpPWpGaD
Lorazepam—Clozapine—CYP1A1—lung cancer	0.000486	0.0283	CrCbGaD
Lorazepam—Chills—Doxorubicin—lung cancer	0.000484	0.000668	CcSEcCtD
Lorazepam—Arrhythmia—Doxorubicin—lung cancer	0.000482	0.000665	CcSEcCtD
Lorazepam—Dizziness—Paclitaxel—lung cancer	0.000479	0.000661	CcSEcCtD
Lorazepam—Nausea—Cisplatin—lung cancer	0.000479	0.000661	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—B4GALT5—lung cancer	0.000479	0.00191	CbGpPWpGaD
Lorazepam—Alopecia—Doxorubicin—lung cancer	0.000477	0.000657	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—ADCY1—lung cancer	0.000475	0.00189	CbGpPWpGaD
Lorazepam—GABRB3—respiratory system—lung cancer	0.000474	0.0814	CbGeAlD
Lorazepam—Convulsion—Methotrexate—lung cancer	0.00047	0.000648	CcSEcCtD
Lorazepam—Vomiting—Etoposide—lung cancer	0.00047	0.000648	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—lung cancer	0.00047	0.000648	CcSEcCtD
Lorazepam—Rash—Etoposide—lung cancer	0.000466	0.000643	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GSTA4—lung cancer	0.000466	0.00185	CbGpPWpGaD
Lorazepam—Dermatitis—Etoposide—lung cancer	0.000466	0.000642	CcSEcCtD
Lorazepam—Headache—Etoposide—lung cancer	0.000463	0.000638	CcSEcCtD
Lorazepam—Tension—Doxorubicin—lung cancer	0.000461	0.000636	CcSEcCtD
Lorazepam—Vomiting—Paclitaxel—lung cancer	0.000461	0.000635	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000461	0.00183	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000458	0.00182	CbGpPWpGaD
Lorazepam—Rash—Paclitaxel—lung cancer	0.000457	0.00063	CcSEcCtD
Lorazepam—Dermatitis—Paclitaxel—lung cancer	0.000457	0.000629	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—lung cancer	0.000456	0.000629	CcSEcCtD
Lorazepam—Headache—Paclitaxel—lung cancer	0.000454	0.000626	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GSTA2—lung cancer	0.000454	0.00181	CbGpPWpGaD
Lorazepam—Hypersensitivity—Docetaxel—lung cancer	0.000453	0.000624	CcSEcCtD
Lorazepam—Confusional state—Methotrexate—lung cancer	0.000447	0.000615	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—lung cancer	0.000443	0.00061	CcSEcCtD
Lorazepam—Asthenia—Docetaxel—lung cancer	0.000441	0.000608	CcSEcCtD
Lorazepam—Infection—Methotrexate—lung cancer	0.00044	0.000606	CcSEcCtD
Lorazepam—Nausea—Etoposide—lung cancer	0.000439	0.000605	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GSTA1—lung cancer	0.000438	0.00174	CbGpPWpGaD
Lorazepam—TSPO—epithelium—lung cancer	0.000436	0.0749	CbGeAlD
Lorazepam—GABRA1—Orphan transporters—CREBBP—lung cancer	0.000436	0.00174	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Methotrexate—lung cancer	0.000434	0.000598	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ABCC3—lung cancer	0.000433	0.00172	CbGpPWpGaD
Lorazepam—Agitation—Doxorubicin—lung cancer	0.000432	0.000595	CcSEcCtD
Lorazepam—Nausea—Paclitaxel—lung cancer	0.000431	0.000594	CcSEcCtD
Lorazepam—TSPO—bronchus—lung cancer	0.00043	0.0738	CbGeAlD
Lorazepam—GABRB3—BDNF signaling pathway—APC—lung cancer	0.000422	0.00168	CbGpPWpGaD
Lorazepam—Vertigo—Doxorubicin—lung cancer	0.000422	0.000582	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—AKR1C1—lung cancer	0.00042	0.00167	CbGpPWpGaD
Lorazepam—Hypotension—Methotrexate—lung cancer	0.000414	0.00057	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—UGT1A1—lung cancer	0.000407	0.00162	CbGpPWpGaD
Lorazepam—Convulsion—Doxorubicin—lung cancer	0.000407	0.000561	CcSEcCtD
Lorazepam—Dizziness—Docetaxel—lung cancer	0.000406	0.00056	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000406	0.00162	CbGpPWpGaD
Lorazepam—Hypertension—Doxorubicin—lung cancer	0.000406	0.000559	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000399	0.00159	CbGpPWpGaD
Lorazepam—Somnolence—Methotrexate—lung cancer	0.000394	0.000543	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—GNG11—lung cancer	0.000393	0.00156	CbGpPWpGaD
Lorazepam—Dry mouth—Doxorubicin—lung cancer	0.000391	0.000539	CcSEcCtD
Lorazepam—Vomiting—Docetaxel—lung cancer	0.000391	0.000538	CcSEcCtD
Lorazepam—Rash—Docetaxel—lung cancer	0.000388	0.000534	CcSEcCtD
Lorazepam—Dermatitis—Docetaxel—lung cancer	0.000387	0.000533	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—lung cancer	0.000387	0.000533	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000386	0.00154	CbGpPWpGaD
Lorazepam—TSPO—trachea—lung cancer	0.000386	0.0662	CbGeAlD
Lorazepam—Headache—Docetaxel—lung cancer	0.000385	0.000531	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Methotrexate—lung cancer	0.000382	0.000527	CcSEcCtD
Lorazepam—Fatigue—Methotrexate—lung cancer	0.000382	0.000526	CcSEcCtD
Lorazepam—Infection—Doxorubicin—lung cancer	0.000381	0.000525	CcSEcCtD
Lorazepam—Pain—Methotrexate—lung cancer	0.000379	0.000522	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—lung cancer	0.000376	0.000518	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—lung cancer	0.000374	0.000516	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—ALDOA—lung cancer	0.000374	0.00149	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAP2K1—lung cancer	0.000374	0.00149	CbGpPWpGaD
Lorazepam—Nitrazepam—ABCB1—lung cancer	0.00037	0.0216	CrCbGaD
Lorazepam—Nausea—Docetaxel—lung cancer	0.000365	0.000503	CcSEcCtD
Lorazepam—Feeling abnormal—Methotrexate—lung cancer	0.000365	0.000503	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000365	0.00145	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCOA3—lung cancer	0.000363	0.00144	CbGpPWpGaD
Lorazepam—TSPO—cardiac atrium—lung cancer	0.000363	0.0622	CbGeAlD
Lorazepam—Hypotension—Doxorubicin—lung cancer	0.000358	0.000494	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000358	0.00143	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ADCY1—lung cancer	0.000353	0.00141	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCG2—lung cancer	0.000353	0.00141	CbGpPWpGaD
Lorazepam—Chlorprothixene—ABCB1—lung cancer	0.000353	0.0205	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000349	0.00139	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ENO2—lung cancer	0.000346	0.00138	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HPGDS—lung cancer	0.000346	0.00138	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPP2R1B—lung cancer	0.000344	0.00137	CbGpPWpGaD
Lorazepam—Somnolence—Doxorubicin—lung cancer	0.000341	0.00047	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.00034	0.00135	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000339	0.00135	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTT1—lung cancer	0.000336	0.00134	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000334	0.00133	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000333	0.00132	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCLC—lung cancer	0.000332	0.00132	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP2A6—lung cancer	0.000332	0.00132	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—RAF1—lung cancer	0.000332	0.00132	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000331	0.000456	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000331	0.00132	CbGpPWpGaD
Lorazepam—Fatigue—Doxorubicin—lung cancer	0.000331	0.000456	CcSEcCtD
Lorazepam—Flurazepam—ABCB1—lung cancer	0.000329	0.0192	CrCbGaD
Lorazepam—Constipation—Doxorubicin—lung cancer	0.000328	0.000452	CcSEcCtD
Lorazepam—Pain—Doxorubicin—lung cancer	0.000328	0.000452	CcSEcCtD
Lorazepam—Hypersensitivity—Methotrexate—lung cancer	0.000326	0.00045	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000325	0.00129	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MTOR—lung cancer	0.000324	0.00129	CbGpPWpGaD
Lorazepam—Asthenia—Methotrexate—lung cancer	0.000318	0.000438	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—lung cancer	0.000316	0.000436	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000316	0.00126	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000315	0.00125	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ENO1—lung cancer	0.000315	0.00125	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000313	0.00125	CbGpPWpGaD
Lorazepam—TSPO—bone marrow—lung cancer	0.000306	0.0525	CbGeAlD
Lorazepam—GABRB3—Transmission across Chemical Synapses—BRAF—lung cancer	0.000305	0.00121	CbGpPWpGaD
Lorazepam—Midazolam—ABCB1—lung cancer	0.000305	0.0178	CrCbGaD
Lorazepam—GABRB3—Ion channel transport—RAF1—lung cancer	0.000302	0.0012	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—BRAF—lung cancer	0.0003	0.00119	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CASP3—lung cancer	0.000298	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000297	0.00118	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000297	0.00118	CbGpPWpGaD
Lorazepam—GABRG2—Ion channel transport—RAF1—lung cancer	0.000296	0.00118	CbGpPWpGaD
Lorazepam—Dizziness—Methotrexate—lung cancer	0.000293	0.000404	CcSEcCtD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000292	0.00116	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000292	0.00116	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000292	0.00116	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000291	0.00116	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—JUN—lung cancer	0.000289	0.00115	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000284	0.00113	CbGpPWpGaD
Lorazepam—Hypersensitivity—Doxorubicin—lung cancer	0.000283	0.000389	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CYP2E1—lung cancer	0.000282	0.00112	CbGpPWpGaD
Lorazepam—Vomiting—Methotrexate—lung cancer	0.000282	0.000388	CcSEcCtD
Lorazepam—Rash—Methotrexate—lung cancer	0.000279	0.000385	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—NQO1—lung cancer	0.000279	0.00111	CbGpPWpGaD
Lorazepam—Dermatitis—Methotrexate—lung cancer	0.000279	0.000385	CcSEcCtD
Lorazepam—Headache—Methotrexate—lung cancer	0.000277	0.000382	CcSEcCtD
Lorazepam—TSPO—lung—lung cancer	0.000277	0.0476	CbGeAlD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TF—lung cancer	0.000276	0.0011	CbGpPWpGaD
Lorazepam—Asthenia—Doxorubicin—lung cancer	0.000275	0.000379	CcSEcCtD
Lorazepam—Diazepam—ALB—lung cancer	0.000274	0.016	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TF—lung cancer	0.000272	0.00108	CbGpPWpGaD
Lorazepam—Nausea—Methotrexate—lung cancer	0.000263	0.000363	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—BRAF—lung cancer	0.000262	0.00104	CbGpPWpGaD
Lorazepam—Diazepam—ABCB1—lung cancer	0.000262	0.0152	CrCbGaD
Lorazepam—GABRB3—BDNF signaling pathway—SRC—lung cancer	0.000259	0.00103	CbGpPWpGaD
Lorazepam—GABRA1—Ion channel transport—RAF1—lung cancer	0.000259	0.00103	CbGpPWpGaD
Lorazepam—Clozapine—ABCB1—lung cancer	0.000258	0.015	CrCbGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000256	0.00102	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000255	0.00102	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000255	0.00102	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—RAF1—lung cancer	0.000255	0.00101	CbGpPWpGaD
Lorazepam—Dizziness—Doxorubicin—lung cancer	0.000254	0.00035	CcSEcCtD
Lorazepam—GABRB3—lung—lung cancer	0.000252	0.0432	CbGeAlD
Lorazepam—UGT2B15—Metabolism—STK11—lung cancer	0.000252	0.001	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000251	0.000999	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.00025	0.000996	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—RAF1—lung cancer	0.00025	0.000996	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—STAT3—lung cancer	0.00025	0.000995	CbGpPWpGaD
Lorazepam—Vomiting—Doxorubicin—lung cancer	0.000244	0.000336	CcSEcCtD
Lorazepam—Rash—Doxorubicin—lung cancer	0.000242	0.000333	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—lung cancer	0.000242	0.000333	CcSEcCtD
Lorazepam—Headache—Doxorubicin—lung cancer	0.00024	0.000331	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00024	0.000954	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK3—lung cancer	0.000239	0.000951	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TF—lung cancer	0.000237	0.000944	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—BRAF—lung cancer	0.000234	0.000931	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTP1—lung cancer	0.000233	0.000927	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000233	0.000926	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—BRAF—lung cancer	0.00023	0.000914	CbGpPWpGaD
Lorazepam—Nausea—Doxorubicin—lung cancer	0.000228	0.000314	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CAT—lung cancer	0.000227	0.000902	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCB1—lung cancer	0.00022	0.000877	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—MDM2—lung cancer	0.00022	0.000874	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000219	0.000871	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—TYMS—lung cancer	0.000216	0.000861	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000215	0.000854	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GSTM1—lung cancer	0.000214	0.000851	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000203	0.000809	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP1A1—lung cancer	0.000203	0.000807	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ERCC2—lung cancer	0.000201	0.000801	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—BRAF—lung cancer	0.000201	0.000799	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—MDM2—lung cancer	0.000196	0.00078	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—RAF1—lung cancer	0.000195	0.000777	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—MDM2—lung cancer	0.000192	0.000766	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—RAF1—lung cancer	0.000192	0.000763	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—AVP—lung cancer	0.000192	0.000763	CbGpPWpGaD
Lorazepam—TSPO—lymph node—lung cancer	0.00019	0.0326	CbGeAlD
Lorazepam—GABRG2—Transmembrane transport of small molecules—AVP—lung cancer	0.000188	0.000749	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000187	0.000743	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000186	0.000739	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000183	0.00073	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—HRAS—lung cancer	0.000183	0.000726	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000182	0.000725	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA1—lung cancer	0.000174	0.000693	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—MDM2—lung cancer	0.000168	0.000669	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—RAF1—lung cancer	0.000168	0.000667	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	0.000164	0.000655	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—lung cancer	0.000161	0.000641	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.00016	0.000638	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000159	0.000634	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CG—lung cancer	0.000159	0.000632	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—POMC—lung cancer	0.000151	0.000602	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CREBBP—lung cancer	0.000147	0.000586	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOA1—lung cancer	0.000147	0.000583	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	0.000144	0.000573	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000141	0.00056	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	0.00014	0.000559	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CD—lung cancer	0.00014	0.000556	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALB—lung cancer	0.000138	0.000549	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000138	0.000548	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000126	0.000501	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000124	0.000494	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000122	0.000485	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CB—lung cancer	0.000122	0.000484	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—lung cancer	0.000121	0.00048	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	0.00012	0.000479	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	0.000116	0.000462	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	0.000114	0.000454	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—HRAS—lung cancer	0.000108	0.000428	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000106	0.000424	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—HRAS—lung cancer	0.000106	0.00042	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTEN—lung cancer	0.000105	0.000419	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	0.000105	0.000418	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	0.000103	0.00041	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—EP300—lung cancer	0.0001	0.000399	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	9.97e-05	0.000397	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—HRAS—lung cancer	9.23e-05	0.000367	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	9.01e-05	0.000359	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CA—lung cancer	7.42e-05	0.000295	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—lung cancer	6.06e-05	0.000241	CbGpPWpGaD
